Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec-Reference-Cited by-同舟云学术

Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec

Published:2012-09 Issue:1-2 Volume:107 Page:49-54
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Larochelle Jean,Alvarez Fernando,Bussières Jean-François,Chevalier Isabelle,Dallaire Louis,Dubois Josée,Faucher Frédéric,Fenyves Daphna,Goodyer Paul,Grenier André,Holme Elisabeth,Laframboise Rachel,Lambert Marie,Lindstedt Sven,Maranda Bruno,Melançon Serge,Merouani Aicha,Mitchell John,Parizeault Guy,Pelletier Luc,Phan Véronique,Rinaldo Piero,Scott C. Ronald,Scriver Charles,Mitchell Grant A.

Funder

Garrod Society of Canada

Groupe d'Aide aux Enfants Tyrosinémiques du Québec (GAETQ)

Faculty of Medicine of the Université de Montréal (to GM)

Swedish Cancer Society

Food and Drug Administration USA

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference21 articles.

1. Hypertyrosinemia;Mitchell,2001

2. Treatment of hereditary tyrosinaemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase;Lindstedt;Lancet,1992

3. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I;Grompe;N. Engl. J. Med.,1994

4. Human genetics: lessons from Quebec populations;Scriver;Annu. Rev. Genomics Hum. Genet.,2001

5. Population history and its impact on medical genetics in Quebec;Laberge;Clin. Genet.,2005

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1;GENETICS;2024-08-23

2. Consenso mexicano de tirosinemia tipo 1;Boletín Médico del Hospital Infantil de México;2024-07-13

3. Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation;Canadian Liver Journal;2024-02-26

4. Developmental and Inherited Liver Disease;MacSween's Pathology of the Liver;2024

5. A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone;International Journal of Neonatal Screening;2023-12-04